Viewing Study NCT00702494


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-25 @ 11:48 PM
Study NCT ID: NCT00702494
Status: COMPLETED
Last Update Posted: 2022-03-16
First Post: 2008-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours
Sponsor: BioInvent International AB
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module